The Experimental Oxime K027—A Promising Protector From Organophosphate Pesticide Poisoning. A Review Comparing K027, K048, Pralidoxime, and Obidoxime
Poisoning with organophosphorus compounds (OPCs) is a major problem worldwide. Standard therapy with atropine and established oxime-type enzyme reactivators (pralidoxime, obidoxime) is unsatisfactory. In search of more efficacious broad-spectrum oximes, new bispyridinium (K-) oximes have been synthe...
Main Authors: | Dietrich E. Lorke, Georg A. Petroianu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-05-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnins.2019.00427/full |
Similar Items
-
Experimental and Established Oximes as Pretreatment before Acute Exposure to Azinphos-Methyl
by: Dietrich E. Lorke, et al.
Published: (2021-03-01) -
A Comparison of the Potency of the Oxime HLö-7 and Currently Used Oximes (HI-6, Pralidoxime, Obidoxime) to Reactivate Nerve Agent-Inhibited Rat Brain Acetylcholinesterase by in vitro Methods
by: Kamil Kuča, et al.
Published: (2005-01-01) -
Combined Pre- and Posttreatment of Paraoxon Exposure
by: Dietrich E Lorke, et al.
Published: (2020-03-01) -
A Comparison of the Therapeutic Efficacy of Conventional and Modern Oximes Against Supralethal Doses of Highly Toxic Organophosphates in Mice
by: Jiří Kassa
Published: (1998-01-01) -
FDA-Approved Oximes and Their Significance in Medicinal Chemistry
by: Jyothi Dhuguru, et al.
Published: (2022-01-01)